Get started
Author

Raylane A. G. Cambui

Observed names: Cambui RAG, RAG Cambui, Raylane AG Cambui, Raylane Adrielle Gonçalves Cambui, Raylane Adrielle Gonçalves Cambuí, Raylane C Cambuí, Raylane Cambui, Raylane Gonçalves Cambui, Raylane A. G. Cambui
Institution: AC Camargo Hospital
ORCID: 0000-0003-4781-6755
Observed ORCID: 0000-0003-4781-6755
OpenAlex ID: A5020632546
Double-edged sword of inflammasome genetics in colorectal cancer prognosis
2020 · Raylane Adrielle Gonçalves Cambui, Gilmar Ferreira do Espírito Santo, et al. · Clinical Immunology · 19
Severe COVID ‐19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils
2022 · Vinicius N. C. Leal, Milena M. S. Andrade, et al. · Scandinavian Journal of Immunology · 16
The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation
2022 · Raylane Adrielle Gonçalves Cambui, Fernanda Pereira Fernandes, et al. · Journal of Cancer Research and Clinical Oncology · 14
PDF
Cervical carcinoma induces NLRP3 inflammasome activation and IL-1ß release in human peripheral blood monocytes affecting patients’ overall survival
2023 · Fernanda Pereira Fernandes, Raylane Adrielle Gonçalves Cambui, et al. · Clinical & Translational Oncology · 10
A common variant close to the “tripwire” linker region of NLRP1 contributes to severe COVID-19
2022 · Vinicius N. C. Leal, Leandro M. Paulino, et al. · Inflammation Research · 10
PDF
In-vitro NLRP3 functional test assists the diagnosis of cryopyrin-associated periodic syndrome (CAPS) patients: A Brazilian cooperation
2022 · Leonardo Oliveira Mendonca, Myrthes Anna Maragna Toledo-Barros, et al. · Clinical Immunology · 8
PDF
Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR T Cells against Hematologic Malignancies
2025 · Maria Leticia Rodrigues Carvalho, Clara de Oliveira Andrade, et al. · Cancer Research · 4
PDF
Data from Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR T Cells against Hematologic Malignancies
2025 · Maria Leticia Rodrigues Carvalho, Clara de Oliveira Andrade, et al.
Supplementary Data from Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR T Cells against Hematologic Malignancies
2025 · Maria Leticia Rodrigues Carvalho, Clara de Oliveira Andrade, et al.
Targeting PRC2 Enhances the Cytotoxic Capacity of Anti-CD19 CAR T Cells against Hematologic Malignancies
2025 · Maria Letícia Rodrigues Carvalho, Clara Andrade, et al.
Targeting Prc2 Enhances the Antitumor Cytotoxic Capacity of Anti-cd19 Car-t Cells Against Hematological Malignancies
2024 · MLR Carvalho, CO Andrade, et al. · Hematology Transfusion and Cell Therapy
Modulação De Alvos Epigenéticos Como Estratégia Para a Potencialização Da Ação Antitumoral De Linfócitos T
2024 · JPD Santos, MLR Carvalho, et al. · Hematology Transfusion and Cell Therapy
Inverse correlation between NLRP3 and TMEM176B as a possible tool for colorectal cancer progression
2024 · Raylane Adrielle Gonçalves Cambui, Mariela Estefany Vera Roa, et al. · medRxiv
PDF
NLRP1 variants affect B cells sensitivity to DPP9 inhibition
2024 · Mariela Vera Roa, Raylane Gonçalves Cambui, et al. · Research Square
NLRP1 and NLRP3 trigger inflammasome activation in CD8+ T cells of ART-treated HIV patients and contribute differently to their chronic activation
2024 · Mariela Vera Roa, Raylane Gonçalves Cambui, et al. · Research Square
PDF
Distinctive inflammasome activation in individuals allergic to Hymenoptera venoms
2024 · Yamada SM, Mendonça LO, et al. · Arquivos de Asmas Alergia e Imunologia
PDF
NLRP3 and NLRP1/CARD8 pathways differently contribute to pyroptosis of CD8+ T cells of ART-treated HIV patients
2023 · Mariela EGV Roa, Raylane AG Cambui, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Works count: 17
Citation count: 81
H-index: 6
I10-index: 5
Year
Topic
Type